Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Baseline Disease Activity and Steroid Therapy Stratify Risk of COVID-19 in Patients With Inflammatory Bowel Disease

Published:2020-10 Issue:4 Volume:159 Page:1541-1544.e2
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Lukin Dana J.^ORCID,Kumar Anand,Hajifathalian Kaveh,Sharaiha Reem Z.,Scherl Ellen J.,Longman Randy S.,Funez-dePagnier Gabriela,Duenas-Bianchi Lucia,Jacob Vinita,Battat Robert J.,Krisko Tibor,Fortune Brett E.

Funder

AbbVie

Takeda

AstraZeneca

Crohn’s

Colitis Foundation

Janssen

New York Crohn’s Foundation

Pfizer

Genentech

Celgene

Boehringer Ingelheim

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference8 articles.

1. Covid-19 in immune-mediated inflammatory diseases—case series from New York;Haberman;N Engl J Med,2020

2. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study;Bezzio;Gut,2020

3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality Trends in Inflammatory Bowel Disease by Age, Sex, and Race in the United States from 1999 to 2020;Inflammatory Bowel Diseases;2024-09-11

2. Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases;Journal of Translational Autoimmunity;2024-06

3. Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects;Vaccines;2023-08-24

4. SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves;BMC Gastroenterology;2023-07-05

5. COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study;Inflammatory Bowel Diseases;2023-04-17